Literature DB >> 17894798

Increased interleukin-10 production and Th2 skewing in the absence of 5-lipoxygenase.

Daniel DiMeo1, Jun Tian, Juan Zhang, Seiko Narushima, Daniel J Berg.   

Abstract

Eicosanoids (prostaglandins and leukotrienes) are important mediators of inflammatory responses. These lipid mediators may also regulate the production of peptide mediators of the immune system. In this study, we investigated the effect of the absence of 5-lipoxygenase (5-LO)-derived leukotrienes on interleukin (IL)-10 production. IL-10 is a key regulator of immune and inflammatory responses, and previous studies have suggested that prostaglandins effect their immunosuppressive functions in part by stimulation of IL-10 production. We therefore investigated whether leukotriene production would have a similar role in regulation of IL-10 production. We have made the striking observation that absence of 5-LO-derived leukotrienes results in increased IL-10 production with a concomitant decrease in the production of pro-inflammatory cytokines, including tumour necrosis factor (TNF)-alpha and IL-12. Moreover, T-cell cytokine production in the absence of 5-LO-derived leukotrienes results in increased IL-4 production and decreased interferon (IFN)-gamma production. This may be in part secondary to increased IL-10 production and its effects on dendritic cell function resulting in altered T-cell differentiation. These findings indicate that, in addition to the central role leukotrienes play in the acute inflammatory response, endogenous leukotrienes are also important regulators of inflammatory cytokine production, via regulation of IL-10 production and in vivo differentiation of T cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17894798      PMCID: PMC2433306          DOI: 10.1111/j.1365-2567.2007.02694.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  70 in total

Review 1.  Eicosanoids and inflammatory bowel disease: regulation and prospects for therapy.

Authors:  D J Fretland; S W Djuric; T S Gaginella
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1990-12       Impact factor: 4.006

Review 2.  Treatment of asthma with antileukotrienes: first line or last resort therapy?

Authors:  Sven-Erik Dahlén
Journal:  Eur J Pharmacol       Date:  2006-02-28       Impact factor: 4.432

3.  Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen.

Authors:  O Akbari; R H DeKruyff; D T Umetsu
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

4.  Specific inhibition of leukotriene B4 (LTB4)-induced neutrophil emigration by 20-hydroxy LTB4: implications for the regulation of inflammatory responses.

Authors:  E R Pettipher; E D Salter; R Breslow; L Raycroft; H J Showell
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

Review 5.  5-Lipoxygenase.

Authors:  A W Ford-Hutchinson; M Gresser; R N Young
Journal:  Annu Rev Biochem       Date:  1994       Impact factor: 23.643

6.  A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in children with asthma.

Authors:  I Stelmach; J Jerzynska; P Kuna
Journal:  Clin Exp Allergy       Date:  2002-02       Impact factor: 5.018

7.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

Authors:  C S Hsieh; S E Macatonia; C S Tripp; S F Wolf; A O'Garra; K M Murphy
Journal:  Science       Date:  1993-04-23       Impact factor: 47.728

8.  In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokine-mediated granuloma formation.

Authors:  S W Chensue; J H Ruth; K Warmington; P Lincoln; S L Kunkel
Journal:  J Immunol       Date:  1995-10-01       Impact factor: 5.422

9.  Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses.

Authors:  R S Byrum; J L Goulet; R J Griffiths; B H Koller
Journal:  J Exp Med       Date:  1997-03-17       Impact factor: 14.307

10.  Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.

Authors:  H Groux; M Bigler; J E de Vries; M G Roncarolo
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

View more
  11 in total

1.  Montelukast, a cysteinyl leukotriene receptor-1 antagonist protects against hippocampal injury induced by transient global cerebral ischemia and reperfusion in rats.

Authors:  M A Saad; R M Abdelsalam; S A Kenawy; A S Attia
Journal:  Neurochem Res       Date:  2014-11-18       Impact factor: 3.996

2.  Arachidonate 5-lipoxygenase establishes adaptive humoral immunity by controlling primary B cells and their cognate T-cell help.

Authors:  Tsutomu Nagashima; Shingo Ichimiya; Tomoki Kikuchi; Yoshiyuki Saito; Hiroshi Matsumiya; Shihoko Ara; Shigeru Koshiba; Jun Zhang; Chizuru Hatate; Akiko Tonooka; Terufumi Kubo; Rui Carrie Ye; Bungo Hirose; Hideaki Shirasaki; Takashi Izumi; Tsuyoshi Takami; Tetsuo Himi; Noriyuki Sato
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

3.  Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway.

Authors:  Jun Wei; Jason Barr; Ling-Yuan Kong; Yongtao Wang; Adam Wu; Amit K Sharma; Joy Gumin; Verlene Henry; Howard Colman; Waldemar Priebe; Raymond Sawaya; Frederick F Lang; Amy B Heimberger
Journal:  Mol Cancer Ther       Date:  2010-01-06       Impact factor: 6.261

4.  Functional analysis of 5-lipoxygenase promoter repeat variants.

Authors:  Susanna Vikman; Romulo M Brena; Patrice Armstrong; Jaana Hartiala; Charles B Stephensen; Hooman Allayee
Journal:  Hum Mol Genet       Date:  2009-08-28       Impact factor: 6.150

5.  Deletion of 5-Lipoxygenase in the Tumor Microenvironment Promotes Lung Cancer Progression and Metastasis through Regulating T Cell Recruitment.

Authors:  Joanna M Poczobutt; Teresa T Nguyen; Dwight Hanson; Howard Li; Trisha R Sippel; Mary C M Weiser-Evans; Miguel Gijon; Robert C Murphy; Raphael A Nemenoff
Journal:  J Immunol       Date:  2015-12-11       Impact factor: 5.422

6.  Selective inhibition of IFNG-induced autophagy by Mir155- and Mir31-responsive WNT5A and SHH signaling.

Authors:  Sahana Holla; Mariola Kurowska-Stolarska; Jagadeesh Bayry; Kithiganahalli Narayanaswamy Balaji
Journal:  Autophagy       Date:  2013-12-10       Impact factor: 16.016

Review 7.  Polyunsaturated Fatty Acid-derived lipid mediators and T cell function.

Authors:  Anna Nicolaou; Claudio Mauro; Paula Urquhart; Federica Marelli-Berg
Journal:  Front Immunol       Date:  2014-02-25       Impact factor: 7.561

8.  Differences in cNOS/iNOS Activity during Resistance to Trypanosoma cruzi Infection in 5-Lipoxygenase Knockout Mice.

Authors:  Carolina Panis; Vanessa Jacob Victorino; Vera Lúcia Hideko Tatakihara; Rubens Cecchini; Luiz Vicente Rizzo; Lucy Megumi Yamauchi; Sueli Fumie Yamada-Ogatta; Marli Cardoso Martins-Pinge; Phileno Pinge-Filho
Journal:  Mediators Inflamm       Date:  2019-10-24       Impact factor: 4.711

9.  Protective Effects of Quercetin on Livers from Mice Exposed to Long-Term Cigarette Smoke.

Authors:  Pedro A Machado-Junior; Natália P S Araújo; Ana B F Souza; Thalles F Castro; Michel Oliveira; Guilherme P Costa; Natália A Matos; Paula M A Vieira; André Talvani; Frank S Bezerra; Sílvia D Cangussú
Journal:  Biomed Res Int       Date:  2020-11-15       Impact factor: 3.411

10.  yuDetecting the percent of peripheral blood mononuclear cells displaying p-STAT-3 in malignant glioma patients.

Authors:  William Humphries; Yongtao Wang; Wei Qiao; Chantal Reina-Ortiz; Mohamed K Abou-Ghazal; Lamonne M Crutcher; Jun Wei; Ling-Yuan Kong; Raymond Sawaya; Ganesh Rao; Jeffrey Weinberg; Sujit S Prabhu; Gregory N Fuller; Amy B Heimberger
Journal:  J Transl Med       Date:  2009-11-09       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.